Jazz Pharmaceuticals PLC Acquisition of Cavion Inc - M&A Call Transcript
Welcome to the Jazz Pharmaceuticals plc Investor Update Acquisition of Cavion, Inc., Conference Call. Following an introduction from the company, we will open the call to questions.
I will now turn the call over to Kathee Littrell, Head of Investor Relations at Jazz Pharmaceuticals.
Thank you, Carmen, and thank you for joining our investor call today to discuss the acquisition of Cavion and its key product, CX-8998. The press release and the slide presentation accompanying this call are available on the Investor section of our website.
I'd like to remind you that some of the statements we will make on this call relate to future events and performance rather than historical facts and are forward-looking. Examples include statements regarding our future development plans and opportunities for CX-8998. These forward-looking statements involve risks and uncertainties that could cause actual events, performance and results to differ materially. We undertake no duty or obligation to update
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |